Eric W Roberts bought $8,230 of CALC
CHIEF BUSINESS OFFICER at CalciMedica, Inc.. 3,000 shares at an average of $2.74, traded Aug 19, 2025, filed Aug 21, 2025.
Score components
- +15RoleOfficer
- 0Trade size$8k at market
- +3Relative to holdingsHoldings up 6%
- +8Price context44% below the 52-week high
- +8Cluster2 insiders buying within 14 days
- +5Repeat buying10 buys in 90 days
- 0Track recordToo few past buys to judge (2 with prices)
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001415889-25-022550, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Aug 19, 2025 | POpen-market purchase Common Stockindirect: By FMTC Custodian - Roth IRA FBO Eric W. Roberts | +1,000 | $2.79 | $2,790 | 55,399 | Aug 21, 2025 |
| Aug 20, 2025 | POpen-market purchase Common Stockindirect: By FMTC Custodian - Roth IRA FBO Eric W. Roberts | +2,000 | $2.72 | $5,440 | 57,399 | Aug 21, 2025 |
| Aug 20, 2025 | MOption exercise Common Stock | +15,000 | $1.53 | $23k | 179,706 | Aug 21, 2025 |
| Aug 20, 2025 | MOption exercise Employee Stock Option (Right to Buy)derivative | -15,000 | $1.53 | $23k | 57,750 | Aug 21, 2025 |
Related signals
Other insiders at CalciMedica, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 28Weak | CALCbuy CalciMedica, Inc. | Eric W Roberts CHIEF BUSINESS OFFICER | $7,675 2,500 shares | +3% | |
| 28Weak | CALCbuy CalciMedica, Inc. | Eric W Roberts CHIEF BUSINESS OFFICER | $9,105 3,400 shares | +4% | |
| 31Weak | CALCbuy CalciMedica, Inc. | Eric W Roberts CHIEF BUSINESS OFFICER | $16k 5,000 shares | +7% | |
| 24Weak | CALCbuy CalciMedica, Inc. | Eric W Roberts CHIEF BUSINESS OFFICER | $7,378 2,343 shares | +3% | |
| 44Moderate | CalciMedica, Inc. | Eric W Roberts CHIEF BUSINESS OFFICER | $29k 10,000 shares | +16% | |
| 39Weak | CalciMedica, Inc. | Eric W Roberts CHIEF BUSINESS OFFICER | $9,797 3,508 shares | +6% | |
| 44Moderate | CalciMedica, Inc. | Sudarshan Hebbar Chief Medical Officer | $27k 9,563 shares | +18% | |
| 39Weak | CalciMedica, Inc. | Eric W Roberts CHIEF BUSINESS OFFICER | $15k 5,076 shares | +10% | |
| 34Weak | CalciMedica, Inc. | Sudarshan Hebbar Chief Medical Officer | $16k 5,976 shares | +13% | |
| 42Moderate | CalciMedica, Inc. | Kenneth A. Stauderman Chief Scientific Officer | $3,960 1,000 shares | +8% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.